Please use this identifier to cite or link to this item:
|Title:||Cancer related thrombophilia: clinical importance and management strategies.|
|Authors:||Gupta, P K|
Charan, V D
|Citation:||Gupta PK, Charan VD, Kumar H. Cancer related thrombophilia: clinical importance and management strategies. Journal of the Association of Physicians of India. 2005 Oct; 53(): 877-82|
|Abstract:||Acquired thrombophilic state associated with a significant risk of thrombosis is frequently encountered in malignancy. Venous and arterial thromboembolism is a common complication and patients with cancer, also present with a hypercoagulable state, even in the absence of thrombosis. Furthermore, clotting activation may play a role in tumor progression. The pathogenesis of thrombosis in cancer is multifactorial; however, a relevant role is attributed to the tumor cell capacity to interact with and activate the host hemostatic system. Among other factors, the prothrombotic action of antitumor therapies is also important. Thrombotic events can influence the morbidity and mortality of the underlying disease. Therefore, preventing these complications in cancer patients is a clinically relevant issue. Recently, new approaches to the prevention and cure of thrombosis in cancer have been investigated, and the hypothesis that the strategies to inhibit clotting mechanism may favorably affect malignant disease is gaining increasing interest. In this article the various aspects of the complex relationship between thrombosis and cancer, from pathophysiology to therapy, are reviewed.|
|Appears in Collections:||Journal of the Association of Physicians of India|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.